You are here

Radius Health

Radius, fending off activists, outlines pitch for $890 million buyout

BioPharma Dive

Fri, 07/8/22 - 10:44 am

VC firms take osteoporosis drugmaker Radius Health private for almost $900M

Endpoints

Mon, 06/27/22 - 10:04 am

venture capital

Radius falters after a PhIII osteoporosis fail and a breast cancer disappointment, sending shares plummeting

Endpoints

Thu, 12/9/21 - 10:56 am

clinical trials

Menarini, chased by 3 Big Pharmas, records win in breast cancer phase 3, plots path to FDA

Fierce Biotech

Thu, 10/21/21 - 10:35 am

clinical trials

Validation for a drug class, and for Sanofi

EP Vantage

Wed, 05/12/21 - 10:44 am

Kelly Martin skips to a new CEO suite as his last biotech team raises the white flag

Endpoints

Thu, 04/30/20 - 10:36 am

Radius Health Initiates Phase III Trial of Osteoporosis Injection Drug for Males

CP Wire

Mon, 04/2/18 - 03:08 pm

clinical trials

EMA’s CHMP Rejects Two Drugs Approved by US FDA in 2017

RAPS.org

Fri, 03/23/18 - 10:10 am

Portola Pharmaceuticals

Payer coverage boosts Radius' Tymlos

BioPharma Dive

Fri, 08/4/17 - 11:40 am

Express Scripts

Radius' Tymlos gets another big break as Express Scripts boots Lilly's Forteo

Fierce Pharma

Tue, 08/1/17 - 11:49 am

Express Scripts

An Endocrinologist Explains Her View Of Tymlos And The Osteoporosis Landscape

Seeking Alpha

Mon, 07/24/17 - 10:44 am

FDA rejects Amgen’s osteoporosis drug romo as rival Radius surprises with a new CEO

Endpoints

Mon, 07/17/17 - 09:15 am

Amgen's romosozumab red flag on heart safety means a boost for new Radius bone drug

Fierce Pharma

Mon, 05/22/17 - 09:45 am

With Amgen hot on its heels, Radius races to get a jump on osteoporosis drug rivalry

Endpoints

Mon, 05/1/17 - 10:57 am

FDA approves Radius Health's osteoporosis drug Tymlos

Yahoo/Reuters

Sat, 04/29/17 - 10:10 am

Radius shares slide after FDA delays decision on bone drug

BioPharma Dive

Fri, 03/10/17 - 09:03 pm

Amgen’s expectations for romosozumab take a hit as Radius lines up its rival osteoporosis drug

Endpoints

Mon, 09/19/16 - 09:53 am

3 Biotech Stocks With Explosive Upside Potential

Motley Fool

Wed, 08/24/16 - 10:53 am

abaloparatide-SC

Sarepta Therapeutics

Split the pot? Radius shows its osteoporosis cards in final blockbuster match with Amgen

Endpoints

Wed, 08/17/16 - 10:38 am

5 Key FDA Decisions Expected in March

24/7 Wall St

Mon, 03/14/16 - 10:02 am

Alder Biopharmaceuticals

Pages